1. **Specifications table** {#s0005}
===========================

TableSubject areaChemistry, BiologyMore specific subject areaAngiotensin-I converting enzyme inhibitory peptidesType of dataTables of identified sequences and peptide yield enhancement; text description of the data; and figures of ACE inhibitory activities, LC--MS/MS and HPLC for BMSP hydrolysatesHow data was acquiredMass spectrometry, database search, ACE inhibitory assay, SDS-PAGEData formatRaw, filtered, and analyzedExperimental factorsThese are described in the text description of the dataExperimental featuresThese are described in the text description of the dataData source locationPingtung, TaiwanData accessibilityData is supplied in this article

2. **Value of the data** {#s0010}
========================

•Peptides identified from hydrolysate of bitter melon (*Momordica charantia*) seed proteins could be developed into food products.•The approach we took to quantitative analysis of active peptides using LC--MS/MS under the mode of multiple reaction monitoring could be useful to others.•Others interested in how to optimize peptide yield from natural sources could learn from our approach to tuning hydrolysis conditions, monitored by HPLC.

3. **Data** {#s0015}
===========

ACE inhibitory activities of five BMSP hydrolysates (which were derived from trypsin, α-chymotrypsin, pepsin, alcalase, and thermolysin) were evaluated using *in vitro* ACE inhibitory assay. The identified peptides were analyzed using LC--MS/MS. The yields of VY-7 at various hydrolysis conditions were examined using LC--MS/MS (MRM mode) and HPLC.

4. **Experimental design, materials and methods** {#s0020}
=================================================

4.1. Peptide identification using in-gel digestion, LC--MS/MS analysis and database matching {#s0025}
--------------------------------------------------------------------------------------------

Bitter melon seed proteins (BMSPs) were separated using SDS-PAGE to give several distinct bands [@bib1]. Five protein bands were in-gel digested by trypsin and the resulting peptides were analyzed using LC--MS/MS and Mascot database search. The data indicated that momordin A (protein source of VY-7) was located at the most intensive band positions with molecular weight around 28 kDa. The identified peptides derived from this protein are summarized in [Table S1](#s0045){ref-type="fn"} in Supplementary information.

4.2. ACE inhibitory assay of BMSPs hydrolysates derived from different enzymes. {#s0030}
-------------------------------------------------------------------------------

BMSPs were digested using different proteolytic enzymes, trypsin (pH 8, 37 °C), α-chymotrypsin (pH 8, 37 °C), pepsin (pH 1.5, 37 °C), alcalase (pH 8, 50 °C), and thermolysin (pH 8, 60 °C). The hydrolysates derived from different enzymes were ultrafiltrated using 3 kDa MWCO ultrafiltration membranes and the resulting filtrates were lyophilized and subjected individually to ACE inhibitory assay according to previous report [@bib2]. Data is shown in [Fig. 1](#f0005){ref-type="fig"}.

4.3. Quantitative analysis of VY-7 in BMSPs hydrolysate using LC--MS/MS. {#s0035}
------------------------------------------------------------------------

To determine the content of VY-7 in crude BMSPs hydrolysate, multiple reaction monitoring (MRM) was performed in LC--MS/MS analysis of BMSPs hydrolysate, similar to our previous report [@bib3]. The MRM transition of VY-7 was set to be *m*/*z* 709.7\>181.7 and 243.8 under a collision-induced dissociation (CID) energy of 40 V. Using the same LC--MS/MS condition, the calibration curve was established based on six standard peptide solutions at concentrations from 50 pg/µL to 25 ng/µL. The content of VY-7 in each BMSPs hydrolysate was determined according to its peak area in the MRM chromatogram. The full scan and VY-7 MRM chromatogram of BMSP hydrolysate are shown in [Fig. 2](#f0010){ref-type="fig"}. Moreover, the standard peptide was also spiked into crude BMSPs hydrolysate to confirm the quantification of the results based on the retention time and the spike yield (based on peak area), as shown in [Fig. 2](#f0010){ref-type="fig"}(C).

4.4. Optimization of target peptide formation by tuning hydrolysis conditions. {#s0040}
------------------------------------------------------------------------------

To increase the yield of VY-7, the hydrolysis conditions, in terms of enzyme-to-protein ratios (w/w) (1/50, 1/100, 1/200, 1/400, and 1/800), hydrolysis times (1, 3, 6, 9, 12, and 15 h) and temperatures of incubation (40, 50, 60, and 70 °C), were optimized, using an approach similar to our previous report [@bib4]. The optimum condition was defined as the condition which could produce the highest amount of target peptide. The yield of VY-7 in each hydrolysis condition was calculated based on MRM analysis, as mentioned in [Section 4.3](#s0035){ref-type="sec"}. The results are shown in [Table 1](#t0005){ref-type="table"}. Using the optimum condition, an *E*/*S* ratio of 1:100 (w/w) was obtained with hydrolysis time of 12 h at 60 °C and 14.89±0.88 μg of VY-7 can be formed from 1 mg of BMSPs. The HPLC peptide patterns before and after hydrolysis optimization are shown in [Fig. 3](#f0015){ref-type="fig"}. The yield of target peptide was dramatically improved when the optimum conditions were used.

Appendix A. Supplementary material {#s0050}
==================================

Supplementary material
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![ACE inhibitory activities of the BMSP hydrolysates digested using different proteolytic enzymes. The hydrolysates derived from different enzymes were ultrafiltrated using 3 kDa MWCO ultrafiltration membranes and the resulting filtrates were lyophilized and subjected individually to ACE inhibitory assay.](gr1){#f0005}

![LC--MS/MS chromatograms. (A) Full chromatogram of the BMSP thermolysin digest; (B) MRM of VY-7 in the crude thermolysin digest of BMSPs; and (C) MRM chromatogram of synthetic VY-7 spiked in the BMSP thermolysin digest.](gr2){#f0010}

![HPLC chromatograms of the BMSP thermolysin hydrolysate digested using condition (A) before; and (B) after optimization. The target peptide VY-7 is located between the two dotted lines.](gr3){#f0015}

###### 

Effects of enzyme to substrate ratio (w/w), hydrolysis time (h), and temperature (°C) on peptide amount (μg/mg).

Table 1

  ***E*/*S* ratio**   **Hydrolysis time (h)**   **Temperature (**°**C)**   **Peptide amount (μg/mg)**
  ------------------- ------------------------- -------------------------- ----------------------------
  1:50                12                        60                         10.20±0.84
  1:100               14.89±0.88                                           
  1:200               10.65±0.85                                           
  1:400               4.21±0.44                                            
  1:800               2.78±0.05                                            
  1:100               1                         2.05±0.25                  
  3                   3.96±0.79                                            
  6                   7.77±0.48                                            
  9                   10.34±0.68                                           
  15                  2.48±0.26                                            
  12                  40                        4.42±0.23                  
  50                  8.05±0.27                                            
  70                  1.49±0.05                                            
